Scisparc Ltd
NASDAQ:SPRC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Scisparc Ltd
NASDAQ:SPRC
|
IL |
|
T
|
Takachiho Koheki Co Ltd
TSE:2676
|
JP |
|
S
|
Sungei Bagan Rubber Company Malaya Bhd
KLSE:SBAGAN
|
MY |
|
Precision Drilling Corp
TSX:PD
|
CA |
|
W
|
WidePoint Corp
AMEX:WYY
|
US |
|
S
|
Shreyas Intermediates Ltd
BSE:526335
|
IN |
|
INOVIQ Ltd
ASX:IIQ
|
AU |
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
US |
|
Sino Hotels (Holdings) Ltd
HKEX:1221
|
HK |
|
Y
|
Yoshi Innovation SA
WSE:YOS
|
PL |
|
Wealthking Investments Ltd
HKEX:1140
|
HK |
|
I
|
Indian Oil Corporation Ltd
BSE:530965
|
IN |
|
G
|
Guangdong New Grand Long Packing Co Ltd
SZSE:002836
|
CN |
|
Ostin Technology Group Co Ltd
NASDAQ:OST
|
CN |
|
M
|
Majuba Hill Copper Corp
CNSX:JUBA
|
CA |
Scisparc Ltd
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
